An orthogonal approach to lipid nanoparticle analysis is recommended to optimize drug development success.
Hanna Jankevics Jones
Advertisement
Hanna Jankevics Jones, PhD, is a pharmaceutical segment marketing manager at Malvern Panalytical.
Articles by Hanna Jankevics Jones
Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.
Advertisement
Latest Updated Articles
Shining a Light on Lipid Nanoparticle CharacterizationSeptember 15th 2022
- Taking a Closer Look at Lipid Nanoparticle Characterization
November 8th 2022
Advertisement
Advertisement